BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32552892)

  • 1. A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies.
    Zolfaghari MA; Karimi A; Kalantari E; Korourian A; Ghanadan A; Kamyab K; Esmaili N; Emami Razavi AN; Madjd Z
    BMC Cancer; 2020 Jun; 20(1):567. PubMed ID: 32552892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
    Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
    Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
    Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
    Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
    Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
    Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions.
    Suhonen V; Siiskonen H; Suni M; Rummukainen J; Mannermaa A; Harvima IT
    Eur J Dermatol; 2022 Apr; 32(2):187-194. PubMed ID: 35866898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
    Kadeh H; Saravani S; Heydari F; Shahraki S
    Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
    Bakry OA; Samaka RM; Shoeib MA; Megahed DM
    Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
    Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
    Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
    Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
    Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and pathological aspects of skin cancer in North East of Romania.
    Andrese E; Solovăstru LG; Taranu T; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of SOX2 in non-melanoma skin cancer.
    Abdou AG; Mostafa AF; Gafar S; Farag AGA
    J Cosmet Dermatol; 2022 Jun; 21(6):2623-2628. PubMed ID: 34496119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
    Seleit I; Bakry OA; Samaka RM; Malak MA
    Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferentially expressed antigen in melanoma expression in nonmelanoma skin cancers and melanocytes in surrounding skin.
    Elsensohn A; Hanson J; Ferringer T
    J Cutan Pathol; 2021 Sep; 48(9):1150-1155. PubMed ID: 33719089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide N-methyltransferase in nonmelanoma skin cancers.
    Pompei V; Salvolini E; Rubini C; Lucarini G; Molinelli E; Brisigotti V; Pozzi V; Sartini D; Campanati A; Offidani A; Emanuelli M
    Eur J Clin Invest; 2019 Dec; 49(12):e13175. PubMed ID: 31571214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature.
    Holic L
    Med Oncol; 2024 May; 41(6):157. PubMed ID: 38758457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.